BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

TwoXAR

TwoXAR logo

Founded
2014
Geography
United States of America based
Funding
$14.300 M

The convergence of big data, cloud computing, and artificial intelligence has allowed twoXAR to build a drug discovery platform that is order of magnitudes faster, cheaper, and more accurate than traditional wet-lab based approaches.

twoXAR leverages its technology internally to build its own pipeline of therapeutic candidates across diseases as well as collaborate with biotechnology and pharmaceutical companies to jointly discover and develop novel drug candidates by:

- Screening compound libraries for efficacy against a disease or list of diseases
- Screening compound libraries for efficacy against a disease or list of diseases
- Identifying biologic targets from the elucidation of novel biology

Technologies

AI Companies (Drug Discovery)   Pharmaceutical and Drug Discovery  


Posts Mentioning This Company

Biopharma Insights

R&D Platform

Screen compound libraries for efficacy against a disease, identify new drug candidates from a public library, and identify biologic targets. Allows researchers to: Speed and reduce costs for drug discovery.


Pipelines

None
Preclinical  |  Visit website

twoXAR Pharmaceuticals has rapidly identified potential new therapies for a wide range of diseases and currently has a pipeline for over 18 different disease programs.

Products

 

Services

No services posted yet